Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,369,733 papers from all fields of science
Search
Sign In
Create Free Account
PDPK1 gene
Known as:
3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1
, 3-Phosphoinositide Dependent Protein Kinase-1 Gene
, 3-phosphoinositide dependent protein kinase 1
Expand
This gene plays a role in cellular signaling and development.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
3-Phosphoinositide Dependent Protein Kinase-1
PDPK1 protein, human
Phosphorylation
Serine/Threonine Phosphorylation
Expand
Narrower (1)
PDPK1 wt Allele
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Inositol Deficiency Increases Neural Tube Defect Susceptibility by PI3K/AKT Signaling Pathway (P11-009-19).
Jin Guo
,
Jianhua Wang
Current Developments in Nutrition
2019
Corpus ID: 195188118
Objectives To explore the possible mechanisms of inositol deficiency in neural tube defects (NTDs). Methods The gas…
Expand
2018
2018
Functional Proteomics and Deep Network Interrogation Reveal a Complex Mechanism of Action of Midostaurin in Lung Cancer Cells*
Claudia Ctortecka
,
V. Palve
,
+9 authors
U. Rix
Molecular & Cellular Proteomics
2018
Corpus ID: 52277522
Phenotypic drug screening identified the clinical PKC inhibitor midostaurin to have potent activity in several lung cancer cells…
Expand
2018
2018
miR-718 is involved in malignancy of papillary thyroid cancer through repression of PDPK1.
Xiuyan Wang
,
M. Qi
Pathology, Research and Practice
2018
Corpus ID: 52137064
2018
2018
A new and important relationship between miRNA‐147a and PDPK1 in radiotherapy
Li-Juan Wang
,
Na-na Li
,
+7 authors
Ping Xu
Journal of Cellular Biochemistry
2018
Corpus ID: 3589480
It was found that the expression level of miR‐147a was significantly increased and the pathway of PI3K/AKT was dramatically…
Expand
2017
2017
Abstract P3-03-05: PI3K/PDK1 mediates resistance to CDK4/6 inhibitors through dysregulation of S-phase cyclins/cyclin dependent kinases (CDKs)
V. Jansen
,
L. Formisano
,
+5 authors
C. Arteaga
2017
Corpus ID: 78898733
Background: CDK4/6 inhibitors in combination with antiestrogens are approved for the treatment of ER+ advanced breast cancer…
Expand
2016
2016
Abstract PD2-06: Inhibition of 3-phosphoinositide dependent protein kinase 1 (PDK1) synergizes with CDK4/6 inhibitors against ER-positive breast cancer
V. Jansen
,
N. Bhola
,
+4 authors
C. Arteaga
2016
Corpus ID: 77313567
Background: Dysregulation in cell cycle checkpoints is common in cancer. Small molecule inhibitors that target the CDK4/6…
Expand
2015
2015
MicroRNA profiling identifies miR-129-5p as a regulator of EMT in tubular epithelial cells.
Yanlin Li
,
Hai-wen An
,
J. Pang
,
Lin Huang
,
Jinshan Li
,
Lin-na Liu
International Journal of Clinical and…
2015
Corpus ID: 24367537
The importance of microRNAs in various diseases has been demonstrated, but their potential role in the pathogenesis of renal…
Expand
2015
2015
Abstract 1754: BPR2P001S0, a Coumarin derivative, induced cell cycle arrest in A549 through inhibiting PDPK1 activity
Pi-Han Lin
,
Tzu-Ming Jao
,
Yu-Lin Hung
,
H. Hsieh
,
Ya-Chien Yang
,
Sui‐Yuan Chang
2015
Corpus ID: 78592254
Lung cancer is one of the most common causes of cancer deaths in the world, and the emergence of resistant lung cancer cells can…
Expand
2011
2011
Abstract 4481: Topical application of the dual PDPK1/AKT inhibitor PHT-427 inhibits signaling and growth of human breast cancer cutaneous metastases in mice
D. Kirkpatrick
,
J. Johnson
,
Robert Lemos
,
Mena Abdelemelek
,
Nathan T Ihle
,
G. Powis
2011
Corpus ID: 73196501
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL Despite advances in the treatment of breast cancer…
Expand
2006
2006
Zinc as an insulin replacement in hybridoma cultures.
Victor Wong
,
P. M. Nissom
,
Siow-Leng Sim
,
Jessna H. M. Yeo
,
S. Chuah
,
M. Yap
Biotechnology and Bioengineering
2006
Corpus ID: 20917359
There are many advantages to the use of protein-free media for biologics production, including a reduced risk of viral…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE